Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis

J Poorolajal, E Hooshmand, H Mahjub, N Esmailnasab… - Public health, 2016 - Elsevier
Background The life expectancy of patients with human immunodeficiency virus/acquired
immunodeficiency syndrome (HIV/AIDS) reported by several epidemiological studies is …

Pathogenesis and clinical implications of HIV-related anemia in 2013

AJ Redig, N Berliner - Hematology 2013, the American Society …, 2013 - ashpublications.org
Anemia is a common feature of HIV-related disease and has been uniformly demonstrated
to be an independent predictor of morbidity and mortality. Although anemia often responds …

CD4: CD8 ratio and CD8 count as prognostic markers for mortality in human immunodeficiency virus–infected patients on antiretroviral therapy: the Antiretroviral …

A Trickey, MT May, P Schommers, J Tate… - Clinical Infectious …, 2017 - academic.oup.com
Background We investigated whether CD4: CD8 ratio and CD8 count were prognostic for all-
cause, AIDS, and non-AIDS mortality in virologically suppressed patients with high CD4 …

Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India

G Alvarez-Uria, PK Naik, R Pakam, M Midde - Global health action, 2013 - Taylor & Francis
Background Studies from sub-Saharan Africa have shown high incidence of attrition due to
mortality or loss to follow-up (LTFU) after initiating antiretroviral therapy (ART). India is the …

Marked sex differences in all‐cause mortality on antiretroviral therapy in low‐and middle‐income countries: a systematic review and meta‐analysis

SW Beckham, C Beyrer, P Luckow… - African Journal of …, 2016 - journals.lww.com
Marked sex differences in all‐cause mortality on antiretrovi... : African Journal of Reproduction
and Gynaecological Endoscopy Marked sex differences in all‐cause mortality on antiretroviral …

Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial

O Marcy, D Laureillard, Y Madec, S Chan… - Clinical infectious …, 2014 - academic.oup.com
Background. Shortening the interval between antituberculosis treatment onset and initiation
of antiretroviral therapy (ART) reduces mortality in severely immunocompromised human …

Mortality, AIDS-morbidity, and loss to follow-up by current CD4 cell count among HIV-1–infected adults receiving antiretroviral therapy in Africa and Asia: Data From …

D Gabillard, C Lewden, I Ndoye, R Moh… - JAIDS Journal of …, 2013 - journals.lww.com
Background: In resource-limited countries, estimating CD4-specific incidence rates of
mortality and morbidity among patients receiving antiretroviral therapy (ART) may help …

Are there differences in disease progression and mortality among male and female HIV patients on antiretroviral therapy? A meta-analysis of observational cohorts

AI Abioye, AI Soipe, AA Salako, MO Odesanya… - AIDS care, 2015 - Taylor & Francis
Studies examining the sex differences in morbidity and mortality among HIV/AIDS patients
have yielded inconsistent results. We conducted a meta-analysis of sex differences in …

[HTML][HTML] The clinical utility of the urine-based lateral flow lipoarabinomannan assay in HIV-infected adults in Myanmar: an observational study

SS Thit, NM Aung, ZW Htet, MA Boyd, HA Saw… - BMC medicine, 2017 - Springer
Background The use of the point-of-care lateral flow lipoarabinomannan (LF-LAM) test may
expedite tuberculosis (TB) diagnosis in HIV-positive patients. However, the test's clinical …

[HTML][HTML] Durable suppression of HIV-1 after virologic monitoring-based antiretroviral adherence counseling in Rakai, Uganda

A Billioux, G Nakigozi, K Newell, LW Chang, TC Quinn… - PloS one, 2015 - journals.plos.org
Objectives HIV viral load is recommended for monitoring antiretroviral treatment and
identifying treatment failure. We assessed the durability of viral suppression after viral load …